RxDoctor Payments Data
★ My doctorsLook up a doctor →

Anil Ranawat, MD

Orthopaedic Surgery · New York, NYNPI 1568653947

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 60.8% of it on its own, with 20 other manufacturers making up the rest. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$469,494in general payments, 2019–2025

Across 357 payments — averaging $1315.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$285K
  • Bodycad USA Corp$80K
  • Ranfac Corporation$31K
  • Arthrex$22K
  • Anika Therapeutics, Inc.$20K
  • Globus Medical$10K
  • plus $22K from 15 others
$72,019in research payments, 2019–2025

Across 3 payments — averaging $24,006 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$72K
$27,064in ownership & investment interests, 2019–2025

Across 1 payment — averaging $27,064 each. An ownership or investment interest held by the physician or an immediate family member.

  • Overture Orthopaedics$27K

What the payments were for

  • Consulting fees$273,42558%
  • Speaking & faculty fees$150,84332%
  • Travel & lodging$28,6046%
  • Food & beverage$12,8653%
  • Education$3,7391%
  • Entertainment$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew244$285,282
Bodycad USA Corp37$79,515
Ranfac Corporation6$31,075
Arthrex11$21,745
Anika Therapeutics, Inc.14$19,924
Globus Medical4$10,031
Stryker11$7,704
Linvatec Corporation11$6,965
Gotham Surgical Solutions & Devices, Inc.1$3,739
Xiros Inc4$1,304
Pacira Therapeutics, Inc.1$700
Bone Support Inc.2$625
Overture Orthopaedics2$262
Miach Orthopaedics, Inc.1$177
Ossio Inc2$148
Abanza Inc.1$125
Seapearl East, Inc1$76
Vertex1$47
Moximed, Inc1$18
Amgen1$16
Arteriocyte Medical Systems, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$469,494 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$98,935
Medicare patients
173
Services billed
755

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →